483 Hainan Shuangcheng Pharmaceuticals Jan 2016

483 Hainan Shuangcheng Pharmaceuticals Jan 2016

Peter Baker FDA, Lindsey Schwierjohann FDA$119.00 - Available Now

FDA investigators audited the Hainan Shuangcheng Pharmaceuticals - Hainansheng, China facility and issued inspectional observations (via FDA 483) on 28 Jan 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jan 2016
  • Location: Hainansheng, China
  • FEI: 3009010397
Add To Cart